Facing persistent cases of hospital-onset Methicillin-resistant Staphylococcus aureus (MRSA) during the pandemic, the infection prevention and control (IPC) team at Children’s Hospital New Orleans developed an inexpensive nasal decolonization regimen previously used only in their adult patients that decreased rates of MRSA by 50 percent. Their results are being presented at the Association for Professionals in Infection Control and Epidemiology’s (APIC’s) Annual Conference in Orlando Florida, June 26-28.
J&J receives fifth FDA nod for treating multiple myeloma, with boxed warning and REMS in tow
Johnson & Johnson’s Janssen has received its fifth drug approval for multiple myeloma, securing an accelerated nod for its bispecific Talvey on Thursday morning. The
August 11, 2023